The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen

Eitemau Tebyg

• Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer
  gan: Bottini, A, et al.
  Cyhoeddwyd: (2003)
• Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer
  gan: Milani, Manuela, et al.
  Cyhoeddwyd: (2017)
• Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
  gan: Bottini, A, et al.
  Cyhoeddwyd: (2001)
• Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases
  gan: Generali, D, et al.
  Cyhoeddwyd: (2008)
• Prolyl 4-hydroxylase
  gan: Gorres, Kelly L., et al.
  Cyhoeddwyd: (2010)